These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29241050)

  • 1. Cytokine alterations in panic disorder: A systematic review.
    Quagliato LA; Nardi AE
    J Affect Disord; 2018 Mar; 228():91-96. PubMed ID: 29241050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stress-induced pro- and anti-inflammatory cytokine concentrations in panic disorder patients.
    Petrowski K; Wichmann S; Kirschbaum C
    Psychoneuroendocrinology; 2018 Aug; 94():31-37. PubMed ID: 29754003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine profile in drug-naïve panic disorder patients.
    Quagliato LA; Nardi AE
    Transl Psychiatry; 2022 Feb; 12(1):75. PubMed ID: 35194013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Negative correlation between IL-1β, IL-12 and TNF-γ, and cortisol levels in patients with panic disorder.
    Fernández-Serrano AB; Moya-Faz FJ; Giner Alegría CA; Fernández Rodríguez JC
    Brain Behav; 2022 Jun; 12(6):e2624. PubMed ID: 35588458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in Peripheral C-Reactive Protein and Inflammatory Cytokine Levels in Patients with Panic Disorder: A Systematic Review and Meta-Analysis.
    Liu CH; Hua N; Yang HY
    Neuropsychiatr Dis Treat; 2021; 17():3539-3558. PubMed ID: 34908836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in cytokines between patients with generalised anxiety disorder and panic disorder.
    Zou Z; Zhou B; Huang Y; Wang J; Min W; Li T
    J Psychosom Res; 2020 Jun; 133():109975. PubMed ID: 32220649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased IFN-γ and IL-12 levels in panic disorder.
    Tükel R; Arslan BA; Ertekin BA; Ertekin E; Oflaz S; Ergen A; Kuruca SE; Isbir T
    J Psychosom Res; 2012 Jul; 73(1):63-7. PubMed ID: 22691562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Broad spectrum of cytokine abnormalities in panic disorder and posttraumatic stress disorder.
    Hoge EA; Brandstetter K; Moshier S; Pollack MH; Wong KK; Simon NM
    Depress Anxiety; 2009; 26(5):447-55. PubMed ID: 19319993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of specific association between panicogenic properties of caffeine and HPA-axis activation. A placebo-controlled study of caffeine challenge in patients with panic disorder.
    Masdrakis VG; Markianos M; Oulis P
    Psychiatry Res; 2015 Sep; 229(1-2):75-81. PubMed ID: 26243374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cortisol stress response in post-traumatic stress disorder, panic disorder, and major depressive disorder patients.
    Wichmann S; Kirschbaum C; Böhme C; Petrowski K
    Psychoneuroendocrinology; 2017 Sep; 83():135-141. PubMed ID: 28623762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of experimental panic on neuroimmunological functioning.
    van Duinen MA; Schruers KR; Kenis GR; Wauters A; Delanghe J; Griez EJ; Maes MH
    J Psychosom Res; 2008 Mar; 64(3):305-10. PubMed ID: 18291246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of chemokines, chemokine receptors and interleukin-6 in patients with panic disorder, personality disorders and their co-morbidity.
    Ogłodek EA; Szota AM; Just MJ; Szromek AR; Araszkiewicz A
    Pharmacol Rep; 2016 Aug; 68(4):756-63. PubMed ID: 27208878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cross-sectional healthy-control study of serum inflammatory biomarkers interleukin (IL)-1B and IL-2R in panic disorder patients and their offspring.
    Quagliato LA; Nardi AE
    J Psychiatr Res; 2022 May; 149():260-264. PubMed ID: 35303615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine Levels in Panic Disorder: Evidence for a Dose-Response Relationship.
    Belem da Silva CT; Costa MA; Bortoluzzi A; Pfaffenseller B; Vedana F; Kapczinski F; Manfro GG
    Psychosom Med; 2017; 79(2):126-132. PubMed ID: 28146444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurochemical and genetic factors in panic disorder: a systematic review.
    Moraes ACN; Wijaya C; Freire R; Quagliato LA; Nardi AE; Kyriakoulis P
    Transl Psychiatry; 2024 Jul; 14(1):294. PubMed ID: 39025836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different activation patterns of proinflammatory cytokines in melancholic and non-melancholic major depression are associated with HPA axis activity.
    Kaestner F; Hettich M; Peters M; Sibrowski W; Hetzel G; Ponath G; Arolt V; Cassens U; Rothermundt M
    J Affect Disord; 2005 Aug; 87(2-3):305-11. PubMed ID: 15951024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypothalamic-pituitary-adrenal axis activity in panic disorder: prediction of long-term outcome by pretreatment cortisol levels.
    Abelson JL; Curtis GC
    Am J Psychiatry; 1996 Jan; 153(1):69-73. PubMed ID: 8540595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stress responsive neurohormones in depression and anxiety.
    Ströhle A; Holsboer F
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S207-14. PubMed ID: 14677081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortisol as an indicator of hypothalmic-pitituary-adrenal axis dysregulation in patients with panic disorder: a literature review.
    Jakuszkowiak-Wojten K; Landowski J; Wiglusz MS; Cubała WJ
    Psychiatr Danub; 2015 Sep; 27 Suppl 1():S445-51. PubMed ID: 26417813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased hypothalamus volumes in generalized anxiety disorder but not in panic disorder.
    Terlevic R; Isola M; Ragogna M; Meduri M; Canalaz F; Perini L; Rambaldelli G; Travan L; Crivellato E; Tognin S; Como G; Zuiani C; Bazzocchi M; Balestrieri M; Brambilla P
    J Affect Disord; 2013 Apr; 146(3):390-4. PubMed ID: 23084182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.